vTv Therapeutics
VTVT • NASDAQ
vTv Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul J. Sekhri, with a market cap of $146.9M.
Market Cap$146.9M
Employees16.0
CEOPaul J. Sekhri
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
vTv Therapeutics FAQ
Common questions about vTv Therapeutics
vTv Therapeutics is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $14.0M.
vTv Therapeutics has approximately 16 employees.